In this white paper, Trevor Calkins and Nancy Coffman study the uses of parenteral-grade sucrose in...
Trehalose is a non-reducing disaccharide consisting of two glucose molecules linked by an α, α–1,1 bond.
Pfanstiehl brand high-purity low endotoxin (HPLE) Trehalose is used in the biopharmaceutical industry to stabilise proteins, lipids, and carbohydrates throughout the formulation and freeze / thaw lifecycle of therapeutics.
It is also widely applied as a key component in cryopreservation / freeze media to stabilise cell membranes and improve the recovery and robustness of cells used for bioproduction and cell therapy.
The stabilising benefits of trehalose include but are not limited to:
- Monoclonal antibodies (mAbs)
- Fusion proteins
- Antibody fragments (fAbs)
- Stem cells
Pfanstiehl Brand Trehalose is available as USP-NF (United States Pharmacopoeia — National Formulary), EP (European Pharmacopoeia) and JP (Japanese Pharmacopoeia). Pfanstiehl also holds a US DMF for the Trehalose (T-104-4) product.
Available Package Sizes: 1kg, 5kg, 25kg, 50kg.
In the pharmaceutical industry, products that benefit from the stabilising effects of trehalose include, but...
Pfanstiehl has announced that it will be sponsoring the 2019 Colorado Protein Stability Conference. Taking place...
Sucrose, trehalose, mannitol and maltose are four of the most commonly utilised carbohydrates for protein...